1160653-94-0 Usage
Uses
Used in Organic Synthesis:
3-Bromo-2-fluoro-6-methoxybenzaldehyde is utilized as a building block in organic synthesis for the creation of various biologically active compounds. Its distinctive functional groups and reactivity facilitate the development of new organic molecules with potential applications in various fields.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3-Bromo-2-fluoro-6-methoxybenzaldehyde is employed as a key intermediate for the synthesis of potentially valuable pharmaceuticals. Its unique structure allows for the exploration of new drug candidates with improved therapeutic properties.
Used in Agrochemical Development:
3-Bromo-2-fluoro-6-methoxybenzaldehyde also serves as a versatile intermediate in the development of agrochemicals. Its properties and reactivity are harnessed to create new compounds that can address challenges in agriculture, such as pest control and crop protection.
Used in Chemical Reactions and Mechanisms Study:
Furthermore, 3-Bromo-2-fluoro-6-methoxybenzaldehyde is a useful tool in the study of chemical reactions and mechanisms. Its distinct functional groups and reactivity provide insights into the behavior of similar compounds, aiding in the understanding of complex chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 1160653-94-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,0,6,5 and 3 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1160653-94:
(9*1)+(8*1)+(7*6)+(6*0)+(5*6)+(4*5)+(3*3)+(2*9)+(1*4)=140
140 % 10 = 0
So 1160653-94-0 is a valid CAS Registry Number.
1160653-94-0Relevant articles and documents
METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY
-
Paragraph 0319-0320, (2021/10/02)
Disclosed are methods of treating creatine transporter deficiency, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound that increases transport of a substrate by a mutant or wild-type creatine transporter. Also disclosed are methods of increasing transport of guanidinoacetic acid or a salt thereof across the blood-brain barrier of a mammal, and methods of decreasing accumulation or the concentration of guanidinoacetic acid or a salt thereof in a mammalian cell.
SMALL MOLECULES TARGETING MUTANT MAMMALIAN PROTEINS
-
Paragraph 0457-0458, (2021/12/03)
Disclosed are compounds, compositions, and methods useful for treating or preventing a disease or disorder associated with a mutation in a protein.
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY
-
Page/Page column 105, (2015/06/25)
A series of substituted 3H imidazo[4,5-b]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
SPIROINDOLINONE DERIVATIVES
-
Page/Page column 23, (2009/07/03)
There are provided compounds of the formula and pharmaceutically acceptable salts and esters thereof wherein W, V, X, Y, A, R and R' are as described herein. The compounds are useful as anticancer agents.